Treatment of ovarian cancer in young women

Clinical Obstetrics and Gynecology
David M Gershenson

Abstract

Ovarian cancer accounts for approximately 22,000 cases annually in the United States. Although the vast majority of ovarian cancers occur in postmenopausal women and are of advanced stage, a significant subset occurs in young women. Among those subtypes having a predisposition for young women are malignant ovarian germ cell tumors, sex cord-stromal ovarian tumors, and tumors of low malignant potential. However, invasive epithelial ovarian cancers may also occur in young women, particularly the subtypes of low-grade serous carcinoma and mucinous carcinoma. This article details the diagnosis and optimal treatment of ovarian cancers subtypes in young women.

References

Aug 5, 2004·Obstetrics and Gynecology·Gautam G RaoJohn O Schorge
Mar 24, 2005·Journal of the National Cancer Institute. Monographs·David M Gershenson
Oct 26, 2006·The American Journal of Surgical Pathology·Elvio G SilvaMichael Deavers
Jul 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David M Gershenson
Jul 27, 2007·The New England Journal of Medicine·Lawrence H EinhornRafat Abonour
Apr 14, 2009·Gynecologic Oncology·David M GershensonJohn J Kavanagh
Aug 12, 2009·Cancer·Jason D WrightThomas J Herzog
Jul 29, 2010·Obstetrics and Gynecology·Kathleen M SchmelerPedro T Ramirez
Sep 8, 2010·The New England Journal of Medicine·Ignace VergoteUNKNOWN NCIC Clinical Trials Group
Jan 11, 2011·Gynecologic Oncology·Robert A Burger
May 6, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Gavin C E StuartUNKNOWN Gynecologic Cancer Intergroup
Jun 21, 2011·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

May 22, 2013·Journal of Clinical Monitoring and Computing·David KoberSebastian Haas
Aug 8, 2013·Obstetrical & Gynecological Survey·Sara LangeMichelle Matthews
Sep 12, 2013·PloS One·Michael S AnglesioDavid G Huntsman
Aug 6, 2014·Critical Reviews in Oncology/hematology·Polat DursunAli Ayhan
Apr 30, 2014·Current Oncology Reports·Jubilee Brown, Michael Frumovitz
Apr 10, 2014·Gynecologic Oncology·Hannah S van MeursMarrije R Buist
May 3, 2016·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Ting ZhaoYuan Lu
Feb 9, 2017·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·R Tyler HillmanSteven C Plaxe
Sep 21, 2017·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Dimitrios NasioudisKevin Holcomb
Dec 19, 2019·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Elizabeth A GouldingPeter Sykes
Oct 11, 2017·Clinical Obstetrics and Gynecology·Michael S Anglesio, Paul J Yong
Jul 24, 2013·Expert Review of Anticancer Therapy·Els Van NieuwenhuysenIgnace Vergote
Apr 19, 2017·The Journal of International Medical Research·Ting ZhaoYuan Lu
Aug 9, 2018·Cancers·Jillian R Hufgard WendelShannon M Hawkins
Jul 8, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Vithida Neeyalavira, Prapaporn Suprasert
Oct 1, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I Ray-CoquardUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Aug 6, 2021·BMC Women's Health·Narges ZamaniMitra Modares Gilani
Feb 6, 2021·Journal of the National Comprehensive Cancer Network : JNCCN·Deborah K ArmstrongAnita M Engh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.